The expression of the human organic cation transporter hOCT1 in mammary gland.

被引：3
|
作者：
Dhillon, U
Shenton, J
Cook, V
Harper, P
Watson-Macdonell, J
Ito, S
机构：
[1] Division of Clin. Pharmacol. and Toxicol., Hospital for Sick Children, University of Toronto, Toronto, ON
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1999年 / 65卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(99)80348-8
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
OIIIB1
引用
下载
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [31] Effective dasatinib uptake may occur without human organic cation transporter 1 (hOCT1): implications for the treatment of imatinib-resistant chronic myeloid leukemia
    Giannoudis, Athina
    Davies, Andrea
    Lucas, Claire M.
    Harris, Robert J.
    Pirmohamed, Munir
    Clark, Richard E.
    BLOOD, 2008, 112 (08) : 3348 - 3354
  • [32] Pharmacophore of the stereoselective inhibitor binding site of the human organic cation transporter, hOCT1.
    Moaddel, R.
    Ravichandran, S.
    Bighi, F.
    Yamaguchi, R.
    Collins, J.
    Wainer, I. W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S61 - S61
  • [33] Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3)
    Bourdet, DL
    Pritchard, JB
    Thakker, DR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03): : 1288 - 1297
  • [34] Transcellular transport of organic cations in double-transfected MDCK cells expressing human organic cation transporters hOCT1/hMATE1 and hOCT2/hMATE1
    Sato, Tomoko
    Masuda, Satohiro
    Yonezawa, Atsushi
    Tanihara, Yuko
    Katsura, Toshiya
    Inui, Ken-ichi
    BIOCHEMICAL PHARMACOLOGY, 2008, 76 (07) : 894 - 903
  • [35] The human organic cation transporter (hOCT2) recognizes the degree of substrate ionization
    Barendt, WM
    Wright, SH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (25) : 22491 - 22496
  • [36] Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney
    Urakami, Y
    Kimura, N
    Okuda, M
    Inui, K
    PHARMACEUTICAL RESEARCH, 2004, 21 (06) : 976 - 981
  • [37] Creatinine Transport by Basolateral Organic Cation Transporter hOCT2 in the Human Kidney
    Yumiko Urakami
    Naoko Kimura
    Masahiro Okuda
    Ken-ichi Inui
    Pharmaceutical Research, 2004, 21 : 976 - 981
  • [38] The human organic cation transporter (hOCT2) recognizes the degree of substrate ionization
    Barendt, WM
    Wright, SH
    FASEB JOURNAL, 2002, 16 (04): : A458 - A458
  • [39] EVIDENCE THAT PPAR ACTIVATION MAY CONTROL THE EXPRESSION OF THE IMATINIB TRANSPORTER HOCT1 IN CHRONIC MYELOID LEUKAEMIA
    Wang, L.
    Austin, M.
    Clark, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 44 - 44
  • [40] A new chemotype inhibitor for the human organic cation transporter 3 (hOCT3)
    Pan, Xiaolei
    Iyer, Kavita A.
    Liu, Hebing
    Sweet, Douglas H.
    Dukat, Malgorzata
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (18) : 4440 - 4445
12345